Theratechnologies Цена / балансовая стоимость
Что обозначает Цена / балансовая стоимость в Theratechnologies?
Цена / балансовая стоимость Theratechnologies Inc. является 7.84
Какое определение для Цена / балансовая стоимость?
Отношение рыночной цены акции к её балансовой учётной стоимости представляет собой соотношение между стоимостью акций компании и балансовой стоимостью на акцию.
The price to book ratio, or P/B ratio, is a financial ratio used to compare a company's current market price to its book value. It is also sometimes known as a market to book ratio or price to equity ratio. The calculation of a price to book ratio can be performed in two ways. It can be calculated as the company's market capitalization divided by the company's total book value from its balance sheet. It can also be calculated using per-share values and dividing a company's current share price by the book value per share (i.e. its book value divided by the number of outstanding shares).
The P/B ratio varies between industries. The industries that require more infrastructure capital (for each dollar of profit) will usually trade at P/B ratios much lower than, for example, consulting firms. P/B ratios are commonly used to compare banks, because most assets and liabilities of banks are constantly valued at market values. A higher P/B ratio implies that investors expect management to create more value from a given set of assets, all else equal (and/or that the market value of the firm's assets is significantly higher than their accounting value).
P/B ratios do not, however, directly provide any information on the ability of the firm to generate profits or cash for shareholders. This ratio also gives some idea of whether an investor is paying too much for what would be left if the company went bankrupt immediately. For companies in distress, the book value is usually calculated without the intangible assets that would have no resale value. In such cases, P/B should also be calculated on a "diluted" basis, because stock options may well vest on sale of the company or change of control or firing of management.
Цена / балансовая стоимость компаний в Health Care сектор на NASDAQ по сравнению с Theratechnologies
Что делает Theratechnologies?
theratechnologies inc., a biopharmaceutical company, markets prescription products in the united states, europe, and canada. it offers egrifta and egrifta sv, for the reduction of excess abdominal fat in human immunodeficiency virus (hiv)-infected patients with lipodystrophy; and trogarzo, an injection refers to ibalizumab for the treatment of multidrug resistant hiv-1 infected patients. the company's pipeline products include f8 formulation that could be used for the treatment of hiv-associated lipodystrophy; th-1902 for the treatment of triple negative breast cancer; and th-1904 for the treatment of ovarian cancer. the company was founded in 1993 and is headquartered in montreal, canada.
Компании с цена / балансовая стоимость похож на Theratechnologies
- Eminent Gold имеет Цена / балансовая стоимость из 7.83
- Compania de Distribucion Integral Logista S.A имеет Цена / балансовая стоимость из 7.83
- SML Isuzu имеет Цена / балансовая стоимость из 7.83
- Varian Medical Systems имеет Цена / балансовая стоимость из 7.84
- Eagle Mountain Mining имеет Цена / балансовая стоимость из 7.84
- Wisetech Global имеет Цена / балансовая стоимость из 7.84
- Theratechnologies имеет Цена / балансовая стоимость из 7.84
- Gran Tierra имеет Цена / балансовая стоимость из 7.84
- China Baofeng (International) имеет Цена / балансовая стоимость из 7.84
- Koolearn Technology имеет Цена / балансовая стоимость из 7.84
- eXp World Inc имеет Цена / балансовая стоимость из 7.85
- Firstsource Solutions имеет Цена / балансовая стоимость из 7.85
- Rimbaco Grp Global Ltd имеет Цена / балансовая стоимость из 7.85